Optimizing Care For Management Of Hard To Control Hypertension In Low-Income Patients Across Family Health Centers In New York City
Part of paid clinical trials in New York, New York.
- Sponsor
- NYU Langone Health
- Study ID
- NCT07703423
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Multilevel Hypertension Care Model — BEHAVIORALThe intervention is delivered through the existing My Virtual Care (MVC) Epic-integrated team-based virtual high-risk clinic infrastructure and is adapted specifically for patients with hard-to-control hypertension. It is organized across four levels: 1. Patient-Level Strategies (Individual delivery, remote and in-person) 2. Provider and Health System-Level Strategies (EHR-embedded) 3. Community-Level Strategies (Individual, CHW-navigated) 4. Implementation Support
Study Details
This study will develop and evaluate a multilevel implementation strategy to improve management of hard-to-control hypertension among low-income adults receiving care at the Family Health Centers at NYU Langone Health, a network of federally qualified health centers (FQHCs) in New York City. Using a hybrid mixed-methods implementation science design, the study will be conducted across 9 primary care locations over three phases: a pre-implementation phase to identify contextual barriers using the Consolidated Framework for Implementation Research (CFIR); an implementation phase to deploy and evaluate a multilevel care model; and a post-implementation phase to develop a pragmatic toolkit for scale-up.
Key Dates
- First listed
- Jul 14, 2026
- Start date
- Feb 28, 2027
- Status verified
- Jul 2026
- Primary completion
- Jan 31, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 628 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: InterventionParticipants who attend FHCs assigned to receive the multilevel care model intervention.
- No Intervention: ControlParticipants who attend FHCs that were not assigned to receive the multilevel care model intervention.
Primary Outcome Measure
Change in Systolic Blood Pressure (SBP) [ Time Frame: Baseline, Month 6 ]
Central Contacts
- Olugbenga Ogedegbe, MD646-501-3435
- Valy Fontil646-501-3753
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| NYU Langone Health | New York | New York | 10016 | - |
Find similar trials in New York, NY
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Know Your Pressures NYCNot Yet Recruiting · Columbia University · New York, New York
- BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenTRecruiting · Orchestra BioMed, Inc · Rochester, New York
- Global Paradise System US Post Approval StudyRecruiting · ReCor Medical, Inc. · Sacramento, California